OverviewSuggest Edit

Antidote is a digital health company on a mission to accelerate the breakthroughs of new treatments by bridging the gap between medical research and the people who need them. 
Antidote was launched as TrialReach in 2010 and rebranded to Antidote in 2016. We're based in the U.S. and London, U.K.
TypePrivate
Founded2009
HQLondon, GB
Websiteantidote.me
Employee Ratings3.7

Latest Updates

Employees (est.) (Nov 2020)52(-1%)
Revenue (FY, 2018)£1.5 M(-29%)
Cybersecurity ratingAMore

Key People/Management at Antidote

Pablo Graiver

Pablo Graiver

Founder
Laurent Schockmel

Laurent Schockmel

CEO, Board Member
Keith Lovell

Keith Lovell

CFO, Board Member
Dave Mauro

Dave Mauro

EVP Business Development
Kathy Freeman

Kathy Freeman

Vice President Business Development
Grace McElroy

Grace McElroy

VP Marketing & Partnerships
Show more

Antidote Office Locations

Antidote has offices in London, Carmel and New York
London, GB (HQ)
39 Earlham St
Carmel, US
200 S Rangeline Rd
New York, US
845 3rd Ave floor 6
Show all (3)

Antidote Financials and Metrics

Summary Metrics

Founding Date

2009

Antidote total Funding

$17.9 m

Antidote latest funding size

$13.50 m

Time since last funding

6 years ago

Antidote investors

Antidote's latest funding round in February 2015 was reported to be $13.5 m. In total, Antidote has raised $17.9 m
Show all financial metrics

Antidote Revenue

Embed Graph
View revenue for all periods
Antidote's revenue was reported to be £1.51 m in FY, 2018
GBP

Revenue (FY, 2018)

1.5m

Gross profit (FY, 2018)

447.6k

Gross profit margin (FY, 2018), %

29.6%

Net income (FY, 2018)

(5.3m)

EBIT (FY, 2018)

(5.5m)

Cash (31-Dec-2018)

1.0m
GBPFY, 2015FY, 2016FY, 2017FY, 2018

Revenue

2.2m2.4m2.2m1.5m

Revenue growth, %

8%(11%)

Cost of goods sold

912.3k1.1m892.3k1.1m

Gross profit

1.3m1.3m1.3m447.6k
GBPFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

284.3k1.9m147.5k1.3m2.3m6.1m1.0m

Accounts Receivable

73.1k211.4k504.2k647.1k967.5k509.6k268.6k

Inventories

Current Assets

357.4k2.1m651.8k2.2m3.7m7.2m1.8m
GBPFY, 2015FY, 2016FY, 2017

Net Income

(2.2m)(3.3m)(4.6m)
GBPFY, 2012

Financial Leverage

1.1 x
Show all financial metrics

Antidote Cybersecurity Score

Cybersecurity ratingPremium dataset

A

90/100

SecurityScorecard logo

Antidote Online and Social Media Presence

Embed Graph

Antidote News and Updates

'Star Wars: Squadrons' Is the Soaring Antidote to Force Fatigue

"Permission to jump in an X-wing and blow something up?" "Permission granted."

The Antidote To Peak Uncertainty

The market is facing (at once and together): possible deflation, potential inflation, a second leg of the recession, delayed stagflation, a dollar decline, staggering business bankruptcies, a continued pandemic, a contested election, an unruly transfer of power, and a sickened authoritarian Presi...

Are High-Flying Tech Stocks An Investment Antidote For COVID-19?

Based on investment results so far this year, the answer is decidedly “yes” for many investors.

Cash Is The Best COVID-19 Antidote For Mexican Tech Startups

The spread of the coronavirus and its effects on the world economy have dried up funding for cash-hungry Mexican startups, which must now focus on preserving their balance sheets and weathering the storm.

The Toxic Allure Of Fake Emails -- And How To Deploy The Antidote

The war for the corporate email inbox has only just begun.
Show more

Antidote Blogs

How lab partnerships are key for virtual trials

Amidst the COVID-19 pandemic, finding ways to be innovative with clinical trial patient recruitment has been the name of the game. One trend we’re seeing is the rise of virtual trials, which has made it easier and safer for more people to participate in research. But even if a trial is f…

Interview with Sara Gorman, lupus community advocate

In our work, we’re privileged to meet many patient advocates who are, in their own ways, making life with illness easier for others. Sara Gorman is the owner of a company called Sara Gorman's Pillbags, which creates stylish weekly pill organizers. She has a lupus blog and is the author o…

“Participation for progress,” a new whitepaper in partnership with Antidote, BrightFocus Foundation, and PatientPoint

Antidote partnered with the BrightFocus Foundation and PatientPoint to survey more than 650 patients living with cognitive disorders and their care partners. We sought to understand patterns of diagnosis as well as reasons patients do or do not take part in clinical research — with the u…

How to run the perfect clinical trial recruitment campaign

Many factors play into running a successful clinical trial. Patient recruitment has an infamous reputation for taking a long time and slowing down the research process. However, with the right patient recruitment strategies, enrolling volunteers doesn’t have to halt your trial’s progress…

COPD resources: Where to find the information and support you need

More than 16 million Americans have chronic obstructive pulmonary disease, commonly referred to as COPD, and millions more have it but don’t know it. COPD is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. Emphysema and chronic bronchitis are the two mo…

Advertising clinical trials: Do's and Don'ts

A major challenge in clinical trial advertising is being creative within the scope of institutional review board (IRB) and FDA guidelines, as well as distribution channel rules. While it can take more time and research to craft copy within such narrow parameters, it is definitely still p…
Show more

Antidote Frequently Asked Questions

  • When was Antidote founded?

    Antidote was founded in 2009.

  • Who are Antidote key executives?

    Antidote's key executives are Pablo Graiver, Laurent Schockmel and Keith Lovell.

  • How many employees does Antidote have?

    Antidote has 52 employees.

  • What is Antidote revenue?

    Latest Antidote annual revenue is £1.5 m.

  • What is Antidote revenue per employee?

    Latest Antidote revenue per employee is £29 k.

  • Who are Antidote competitors?

    Competitors of Antidote include Array BioPharma, Amicus Therapeutics and Amarin.

  • Where is Antidote headquarters?

    Antidote headquarters is located at 39 Earlham St, London.

  • Where are Antidote offices?

    Antidote has offices in London, Carmel and New York.

  • How many offices does Antidote have?

    Antidote has 3 offices.